Growth hormone therapy transiently increases apolipoprotein(a) in short β-thalassaemia major children with normal growth hormone reserve

Atherosclerosis

Volumn 128, Issue 2, 1997, Pages 175-182

  Tam, S C F ^a   Pang, R W C ^a   Janus, E D ^a   Kwan, E Y W ^a   Low, L C K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

thalassemia major; apo(a) isoforms; apoliprotein(a); growth hormone therapy; lipoproteins

Indexed keywords

APOLIPOPROTEIN A; GROWTH HORMONE; RECOMBINANT GROWTH HORMONE;

ADOLESCENT; ARTICLE; BETA THALASSEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SHORT STATURE; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ALLELES; APOLIPOPROTEINS A; BETA-THALASSEMIA; BODY HEIGHT; CHILD; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MALE; PHENOTYPE; RECOMBINANT PROTEINS; REFERENCE VALUES; TIME FACTORS;

EID: 0031059053     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)06001-7     Document Type: Article

References (16)

1. Utermann G. The mysteries of lipoprotein(a). Science 1989;246:904.
2. Kung AWC, Pang RWC, Lauder I, Lam KSL, Janus ED. Changes in serum lipoprotein(a) and lipids during treatment of hyperthyroidism. Clin Chem 1995;41:226.
3. Kung AWC, Pang RWC, Janus ED. Elevated serum lipoprotein(a) in subclinical hypothyroidism. Clin Endocrinol 1995;43:445.
4. De Bruin TWA, van Barlingen H, van Linde-Sibenius Trip M, van Vuurst de Vries ARR, Akveld MJ, Erkelens DW. Lipo-protein(a) and apoliproprotein B plasma concentrations in hypothyroid, euthyroid and hyperthyroid subjects. J Clin Endocrinol Metab 1993;76:121.
5. Kim CJ, Jang HC, Cho DH, Min YK. Effects of hormone replacement therapy on lipoprotein(a) and lipids in post-menopausal women. Arterioscler Thromb 1994;14:275.
6. Crook D, Sidhu M, Seed M, O'Donnell M, Stevenson JC. Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid. Atherosclerosis 1992;92:41.
7. Lam KS, Pang RWC, Janus ED, Kung AWC, Wang CCL. Serum apolipoprotein(a) correlates with growth hormone levels in Chinese patients with acromegaly. Atherosclerosis 1993;104:183.
8. Oscarsson J, Wiklund O, Jakobsson KE, Petruson B, Bengtsson BA. Serum lipoproteins in acromegaly before and 6-15 months after transphenoidal adenomectomy. Clin Endocrinol 1994;41:603.
9. Eden S, Wiklund O, Oscarsson J, Rosen T, Bengtsson B. Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb 1993;13:296.
10. Johannsson G, Oscarsson J, Rosen T et al. Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Influence of gender and apo(a) and apoE phenotypes. Arterioscler Thromb Vase Biol 1995;15:2142.
11. Low LCK, Kwan EYW, Lim YJ, Lee ACW, Tam SCF, Lam KSL. Growth hormone treatment of short Chinese children with β-thalassaemia major without GH deficiency. Clin Endocrinol 1995;42:359.
12. Kamboh MI, Ferrell RE, Kottke BA. Expressed hypervariable polymorphism of apolipoprotein(a). Am J Hum Genet 1991;49:1063.
13. Kraft HG, Lingenhel A, Bader G, Kostner GM, Utermann G. The relative electrophoretic mobility of apo(a) isoforms depends on the gel system. Proposal of a nomenclature for apo(a) phenotypes. Atherosclerosis 1995;115(Suppl):536.
14. Kraft HG, Lingenhel A, Pang RWC et al. Frequency distributions of apolipoprotein(a) Kringle IV repeat alleles and their effects on Lp(a) levels in Caucasian, Asian and African populations. The distribution of null alleles is non-random. Eur J Hum Genet 1996;4:74.
15. Goldfarb AW, Rachmilewitz EA, Eisenberg, S. Abnormal low and high density lipoproteins in homozygous β-Thalassaemia. Br J Haematol 1991;79:481.
16. Wass JA, Cudworth AG, Botazzo GF. An assessment of glucose intolerance in acromegaly and its response to medical treatment. Clin Endocrinol 1980;12:53.